Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12-Reference-Cited by-同舟云学术

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12

Published:2016-04-07 Issue:3 Volume:174 Page:382-396
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Srour Samer A.¹²,Devesa Susan S.³,Morton Lindsay M.³,Check David P.³,Curtis Rochelle E.³,Linet Martha S.³,Dores Graça M.¹³

Affiliation:

1. Oklahoma City VA Health Care System; Oklahoma City OK USA

2. Department of Medicine; College of Medicine; University of Oklahoma Health Sciences Center; Oklahoma City OK USA

3. Division of Cancer Epidemiology and Genetics; Department of Health and Human Services; National Cancer Institute; National Institutes of Health; Bethesda MD USA

Funder

Oklahoma City Veterans Affairs Health Care System in Oklahoma City

Intramural Research Program

National Cancer Institute

National Institutes of Health

U.S. Department of Health and Human Services

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14061/fullpdf

Reference64 articles.

1. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera;Abdulkarim;European Journal of Haematology,2010

2. WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes;Alvarez-Larran;British Journal of Haematology,2014

3. Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms;Anderson;American Journal of Hematology,2012

4. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study;Barbui;Journal of Clinical Oncology,2011

5. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis);Barbui;Blood,2012

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential biomarkers and immune characteristics for polycythemia vera-related atherosclerosis using bulk RNA and single-cell RNA datasets: a combined comprehensive bioinformatics and machine learning analysis;Frontiers in Cardiovascular Medicine;2024-08-12

2. Socio-Demographic Determinants of Myelofibrosis Outcomes in an Underserved Center and the SEER National Database;2024-07-26

3. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

4. Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database;Annals of Hematology;2024-07-24

5. Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis;Clinical Lymphoma Myeloma and Leukemia;2024-07